Lysosomal Storage Disorder Drugs Market Size, Share & Industry Analysis, By Therapy Type (Enzyme Replacement Therapy (ERT), Substrate Reduction Therapy (SRT), and Others), By Product (Fabrazyme, Cerezyme, Myozyme/Lumizyme, Nexviazyme, Cerdelga, Aldurazyme, Vimizim, Naglazyme, and Others), By Disease Indication (Gaucher Disease, Fabry Disease, Pompe Disease, MPS I, MPS II, MPS IVA, MPS VI, MPS VII, and Others), By Route of Administration (Intravenous (IV), Intracerebroventricular (ICV), Oral, and Others), By End User (Hospitals, Specialty Clinics, and Others), and Regional Forecast, 2026-2034